Quinapril/Hydrochlorothiazide Tablet — FDA Drug Shortage

Current — Chartwell Molecular Holdings LLC

The FDA lists a drug shortage record for Quinapril/Hydrochlorothiazide Tablet (tablet) from Chartwell Molecular Holdings LLC with status Current. The shortage was first posted on Jan 19, 2023.

Shortage details

Status
Current
Company
Chartwell Molecular Holdings LLC
Package NDC
62135-668-90
Dosage Form
Tablet
Presentation
Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)
Initial Posting
Jan 19, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.